Phase IV Study of Afatinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

被引：0
|
作者：
Thongprasert, Sumitra [1 ]
Boldeanu, Cosmin [2 ]
Radosavljevic, Davorin [3 ]
Petrovic, Marina [4 ]
Jones, Hilary [5 ]
Cseh, Agnieszka [6 ]
Gaafar, Rabab [7 ]
机构：
[1] Chiang Mai Univ, Fac Med, Dept Med, Chiang Mai 50000, Thailand
[2] Braila Cty Emergency Hosp, Braila, Romania
[3] Inst Oncol & Radiol Serbia, Belgrade, Serbia
[4] Clin Ctr Kragujevac, Kragujevac, Serbia
[5] Boehringer Ingelheim Ltd, Dept Oncol, Bracknell, Berks, England
[6] Boehringer Ingelheim Rcv Gmbh & Co Kg, Dept Oncol, Vienna, Austria
[7] Cairo Univ, Natl Canc Inst, Cairo, Egypt
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
afatinib; NSCLC; EGFR mutated; Second-line;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-088
引用
收藏
页码：S667 / S667
页数：1
相关论文
共 50 条
  • [41] Phase Ib Trial of Afatinib and BI 836845 in Advanced Non-Small Cell Lung Cancer (NSCLC)
    Park, Keunchil
    Lin, Chia-Chi
    Huang, Dennis Chin-Lun
    Shin, Heather Hye-Jung
    Bogenrieder, Thomas
    Tan, Daniel S. -W.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S554 - S555
  • [42] Afatinib for the treatment of non-small cell lung cancer
    Biello, Federica
    Maggioni, Claudia
    Rijavec, Erika
    Genova, Carlo
    Barletta, Giulia
    Gualco, Elisa
    Truini, Anna
    Coco, Simona
    Dal Bello, Maria Giovanna
    Vanni, Irene
    Alama, Angela
    Boccardo, Francesco
    Grossi, Francesco
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (11): : 1357 - 1364
  • [43] A phase I study of pernetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer
    Seiwert, Tanguy Y.
    Connel, Philip P.
    Mauer, Ann M.
    Hoffman, Philip C.
    George, Christopher M.
    Szeto, Livia
    Salgia, Ravi
    Posther, Katherine E.
    Nguyen, Binh
    Haraf, Daniel J.
    Vokes, Everett E.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 515 - 522
  • [44] A Phase II Study of Sorafenib in Patients with Locally Advanced And/or Metastatic (stage IIIB or IV) Non-small Cell Lung Cancer (NSCLC) with a K-Ras Mutation
    Dingemans, A. M.
    Mellema, W. W.
    Groen, H. J. M.
    van Wijk, A.
    Burgers, S.
    Kunst, P. W. A.
    Thunnissen, F. B.
    Heideman, D. A. M.
    Smit, E. F.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : 14 - 14
  • [45] ACTIVITY OF PATUPILONE IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY
    Zatloukal, P.
    Mellemgaard, A.
    Sanchez, J. M.
    Perry, M. C.
    Hamm, J. T.
    Van Meerbeeck, J.
    DeLeo, J. J.
    Gao, B.
    Johri, A. R.
    Felip, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
  • [46] Preface - Lung cancer, part I: radiotherapy and chemotherapy in locally advanced and metastatic non-small cell lung cancer
    Jeremic, B
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : XVII - XVIII
  • [47] Is there a standard treatment for locally advanced non-small cell lung cancer?
    Buccheri, G
    CHEST, 1996, 109 (04) : 864 - 866
  • [48] Adjuvant therapy for locally advanced non-small cell lung cancer
    Keller, SM
    LUNG CANCER, 2003, 42 : S29 - S34
  • [49] Surgical Approach to Locally Advanced Non-Small Cell Lung Cancer
    Donington, Jessica S.
    Pass, Harvey I.
    CANCER JOURNAL, 2013, 19 (03): : 217 - 221
  • [50] Trimodality therapy for locally advanced non-small cell lung cancer
    Lackner, R. P.
    Ganti, A.
    Zhen, W.
    Copur, M. S.
    Vaziri, I. A.
    Bolton, M.
    Hlavaty, T.
    Trujillo, K. P.
    Kessinger, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345